Atrial Fibrillation News and Research

RSS
Atrial fibrillation (AF) is the most common arrhythmia. An arrhythmia is a problem with the speed or rhythm of the heartbeat. A disorder in the heart’s electrical system causes AF and other types of arrhythmia. AF occurs when rapid, disorganized electrical signals in the heart’s two upper chambers, called the atria, cause them to contract very fast and irregularly (this is called fibrillation). As a result, blood pools in the atria and isn’t pumped completely into the heart’s two lower chambers, called the ventricles. When this happens, the heart’s upper and lower chambers don’t work together as they should. Often, people who have AF may not even feel symptoms. However, even when not noticed, AF can lead to an increased risk of stroke. In many patients, particularly when the rhythm is extremely rapid, AF can cause chest pain, heart attack, or heart failure. AF may occur rarely or every now and then, or it may become a persistent or permanent heart rhythm lasting for years.
AGA Medical commences enrollment in AMPLATZER Cardiac Plug clinical trial

AGA Medical commences enrollment in AMPLATZER Cardiac Plug clinical trial

BIOTRONIK announces commercial availability of new ProMRI Pacing Systems

BIOTRONIK announces commercial availability of new ProMRI Pacing Systems

Endosense launches ProForce Registry Study of TactiCath force-sensing ablation catheter

Endosense launches ProForce Registry Study of TactiCath force-sensing ablation catheter

Comprehensive source for treatment information of atrial fibrillation in the European market

Comprehensive source for treatment information of atrial fibrillation in the European market

First hospital in Mexico to use GORE HELEX Septal Occluder for transcatheter closure of ASD

First hospital in Mexico to use GORE HELEX Septal Occluder for transcatheter closure of ASD

Dabigatran Etexilate anticoagulant as effective as Enoxaparin in preventing venous thromboembolism

Dabigatran Etexilate anticoagulant as effective as Enoxaparin in preventing venous thromboembolism

Phase 3 AVERROES clinical trial of apixaban for atrial fibrillation closes early due to clear evidence of efficacy

Phase 3 AVERROES clinical trial of apixaban for atrial fibrillation closes early due to clear evidence of efficacy

Arrhythmia Alliance launches 'Know Your Pulse' global awareness campaign on World Heart Rhythm Week

Arrhythmia Alliance launches 'Know Your Pulse' global awareness campaign on World Heart Rhythm Week

CoaguSense unveils first portable point-of-care PT/INR Monitoring System for patients on oral anticoagulants

CoaguSense unveils first portable point-of-care PT/INR Monitoring System for patients on oral anticoagulants

Visually-guided laser-balloon catheter stops abnormal electrical pulses in patients with irregular heartbeats

Visually-guided laser-balloon catheter stops abnormal electrical pulses in patients with irregular heartbeats

Merck, Cardiome Pharma show superiority of BRINAVESS to amiodarone injection

Merck, Cardiome Pharma show superiority of BRINAVESS to amiodarone injection

STOP AF trial: Arctic Front Cardiac CryoAblation Catheter System reduces AF symptoms by 80%

STOP AF trial: Arctic Front Cardiac CryoAblation Catheter System reduces AF symptoms by 80%

Convergent procedure promising for longstanding persistent atrial fibrillation

Convergent procedure promising for longstanding persistent atrial fibrillation

Catheter ablation treatment reduces risks associated with atrial fibrillation

Catheter ablation treatment reduces risks associated with atrial fibrillation

St. Jude Medical announces FDA clearance and CE Mark approval for EnSite Derexi module

St. Jude Medical announces FDA clearance and CE Mark approval for EnSite Derexi module

ARYx Therapeutics decreases first-quarter net loss to $6.4 million

ARYx Therapeutics decreases first-quarter net loss to $6.4 million

Stereotaxis to be featured prominently in 31st HRS

Stereotaxis to be featured prominently in 31st HRS

Children and young adults account for as many as 10% of all stroke cases

Children and young adults account for as many as 10% of all stroke cases

St. Jude Medical to display new products, clinical solutions at Heart Rhythm 2010

St. Jude Medical to display new products, clinical solutions at Heart Rhythm 2010

Merck hosts R&D and Business Briefing

Merck hosts R&D and Business Briefing

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.